155 Evaluating the Clinical Utility and Appropriateness of Four-Factor Prothrombin Complex Concentrates for Anticoagulation Reversal at an Urban, Community Academic Hospital
Saved in:
| Main Authors: | Nicole Thurnherr, Youssef Bessada |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037925001335 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials
by: Christian Ovesen, et al.
Published: (2025-02-01) -
Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding
by: Alexander T. Cohen, et al.
Published: (2022-04-01) -
Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review
by: Craig I Coleman, et al.
Published: (2020-11-01) -
Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice
by: Robert F. Sidonio, Jr., et al.
Published: (2025-05-01) -
Gestational complications of the prothrombin G20210A mutation related to prothrombin activity
by: M. G. Nikolaeva, et al.
Published: (2020-07-01)